Abstract
Background and aims
We evaluated the outcome of primarily resected rectal cancer patients immediately after the implementation of total meserectal excision (TME) based on potential quality indicators.
Patients and methods
Following initial teaching of two staff surgeons (PMS and AHH) by RJ Heald, 164 consecutive patients were analyzed. The following quality indicators were evaluated: (a) frequency of local recurrence, (b) number of resected lymph nodes, (c) selection of operative technique depending on tumor localization, (d) use of a protective loop ileostomy, and (e) frequency and type of adjuvant therapy.
Results
Local recurrence rate was 8.5% after a minimum follow-up of 5 years. An increasing pT category (p < 0.02) and the presence of lymph node metastases (pN+, p < 0.05) were significantly associated with local recurrence rates. The number of resected lymph nodes was significantly associated with nodal metastases rate (p < 0.02). Patients with distal third rectal cancer underwent significantly more often an abdominoperineal amputation (p < 0.0001). Clinical course, but not the rate of anastomotic leakage (9.5%) itself was influenced by using a protective loop ileostomy. Forty-two (29.7%) patients received adjuvant therapy; however, local recurrence rate was higher in patients with adjuvant chemo-/radiotherapy (14.2% vs. 6.1%).
Conclusions
The local recurrence rate of 8.5% demonstrates that through consequent implementation of TME excellent onclogical results can be achieved. The number of resected lymph nodes significantly influenced the pN category. The primary construction of a protective loop ileostomy after TME became standard. Neoadjuvant chemoradiation was systematically introduced in order to improve local tumor control and prevent abdominoperineal amputations. No conclusions can be drawn concerning adjuvant therapy.
Similar content being viewed by others
References
Kapiteijn E, van de Velde CJ (2002) Developments and quality assurance in rectal cancer surgery. Eur J Cancer 38:919–36
Peeters KC, van de Velde CJ (2005) Surgical quality assurance in rectal cancer treatment: the key to improved outcome. Eur J Surg Oncol 31:630–5
Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69:613–616
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet i:1479–1482
MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–60
Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS, Bender JS, Duncan MD, Magnuson TH, Lillemoe KD, Cameron JL (1999) Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 230:404–11
Marusch F, Koch A, Schmidt U, Zippel R, Lehmann M, Czarnetzki HD, Knoop M, Geissler S, Pross M, Gastinger I, Lippert H (2001) Effect of caseload on the short-term outcome of colon surgery: results of a multicenter study. Int J Colorectal Dis 16:362–9
Mack LA, Temple WJ (2005) Education is the key to quality of surgery for rectal cancer. Eur J Surg Oncol 31:636–44
Martling A, Holm T, Rutquist L-E, Moran BJ, Heald RJ, Cedermark B (2000) Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356:93–6
Wibe A, Carlsen E, Dahl O, Tveit KM, Weedon-Fekjaer H, Hestvik UE, Wiig JN, The Norwegian Rectal Cancer Group (2006) Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 8:224–9
UICC (2002) TNM classification of malignant tumours, 6th edn. Sobin LH,Wittekind C (eds) Wiley-Liss, NewYork.
Bittner R, Burghardt J, Gross E, Grundmann RT, Hermanek P, Isbert C, Junginger T, Köckeling F, Merkel S, Möslein G, Raab HR, Roder J, Ruf G, Schwenk W, Strassburg J, Tannapfel A, de Vries A, Zühlke H (2007) Quality indicators for diagnosis and therapy of rectal carcinoma. Zentralblatt Chir 132:85–94
Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, Ballario E, Becchi G, Bonilauri S, Carobbi A, Cavaliere P, Garcea D, Giuliani L, Morziani E, Mosca F, Mussa A, Pasqualini M, Poddie D, Tonetti F, Zardo L, Rosso R (2002) Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 235:458–63
Kim J, Huynh R, Abraham I, Kim E, Kumar RR (2006) Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg 72:902–5
Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, Chu KS, Chan HM, Wang JY (2007) The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg 11:660–5
Schiessel R, Novi G, Holzer B, Rosen HR, Renner K, Hölbling N, Feil W, Urban M (2005) Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 48:1858–65
Wallace MH, Glynne-Jones R (2007) Saving the sphincter in rectal cancer: are we prepared to change practice? Colorectal Dis 9:302–8
Zolciak A, Bujko K, Kepka L, Oledzki J, Rutkowski A, Nowacki MP (2006) Abdominoperineal resection or anterior resection for rectal cancer: patient preferences before and after treatment. Colorectal Dis 8:575–80
Bossema E, Stiggelbout A, Baas-Thijssen M, van de Velde C, Marijnen C (2008) Patients’ preferences for low rectal cancer surgery. Eur J Surg Oncol 34(1):42–48
Gastinger I, Marusch F, Steinert R, Wolff S, Koeckerling F, Lippert H (2005) Working Group ‘Colon/Rectum Carcinoma’. Protective defunctioning stoma in low anterior resection for rectal carcinoma. Br J Surg 92:1137–42
Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R (2007) Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 246:207–14
Arenas RB, Fichera A, Mhoon D et al (1998) Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study. Arch Surg 133:608–611
Tocchi A, Mazzoni G, Lepre L et al (2001) Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrences. Arch Surg 136:216–220
Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–8
Bernardshaw SV, Øvrebø K, Eide GE, Skarstein A, Røkke O (2006) Treatment of rectal cancer: reduction of local recurrence after the introduction of TME—experience from one University Hospital. Dig Surg 23:51–9
Nagtegaal ID, van de Velde, Marijnen CA (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23:9257–64
Merkel S, Mannsmann U, Hohenberger W, Hermanek P (2009) Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment. A systematic review and meta-analysis. Colorectal Disease 13(2):123–131
Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50:103–112
Engel J, Kerr J, Eckel R, Günther B, Heiss M, Heitland W, Jauch KW, Siewert JR, Hölzel D (2005) Quality of treatment in routine care in a population sample of rectal cancer patients. Acta Oncol 44:65–74
Douglass HO Jr, Moertel CG, Mayer RJ et al (1986) Survival after postoperative combination treatment of rectal cancer. N Engl J Med 315:1294–1295
Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715
Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472
O’Connell MJ, Martenson JA, Wieand HS et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507
Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schneider, P.M., Vallbohmer, D., Ploenes, Y. et al. Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management. Int J Colorectal Dis 26, 903–909 (2011). https://doi.org/10.1007/s00384-011-1155-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1155-2